Here's how the news is developing. All times Eastern.
Jan 11, 2022, 12:23 PM EST
New York cases drop for 1st time in weeks
With 48,686 New Yorkers testing positive on Monday, the state saw a case drop for the first time in weeks, Gov. Kathy Hochul announced.
People walk by a Covid-19 vaccination site at a mall near the Staten Island Ferry Terminal, Jan. 5, 2022, in New York City.
Spencer Platt/Getty Images
Hochul called this "a glimmer of hope," but warned, "we are not at the end."
While hospitalizations continue to rise, "the rate of increase is slowing, and to us that is very encouraging," the governor said.
-ABC News' Will Gretsky
Jan 11, 2022, 10:52 AM EST
Chicago handing out 1.5 million KN95 masks
Chicago residents can head to their local alderman's office to get a free KN95 mask as the city distributes 1.5 million of them on Tuesday, ABC Chicago station WLS reported.
With another 4,793 daily cases, Chicago's test positivity rate stands at 18.9% as of Tuesday, according to city data.
Jan 11, 2022, 10:25 AM EST
Feds buy more monoclonal treatment that fights omicron
The U.S. government is buying 600,000 more doses of sotrovimab, the only the monoclonal antibody treatment expected to hold up against omicron, according to the drug makers, GlaxoSmithKline and Vir Biotechnology.
These doses are set to be delivered to the government over the next two months, the drug makers said.
This brings total sotrovimab doses purchased by the federal government to approximately 1 million.
A sign advertises a "Monoclonal Antibody Infusion Center" for coronavirus disease patients at the CHA Everett Hospital in Everett, Mass., Dec. 29, 2021.
Brian Snyder/Reuters, FILE
Until recently the government had not invested in buying bulk stock of sotrovimab, as it has with other monoclonal treatments. The government spent billions buying Regeneron and Eli Lilly's products to ensure there would be enough supply, but both of those may not hold up against omicron.